published meta-analysis   sensitivity analysis   studies

ivermectin in COVID-19 (hospitalized or not) - Summary of results

OutcomeTE95% CInkI2ROBPub. bias viral clearance by day 7detailed resultsNCT04429711 (Biber), 2020 2.62 [1.06; 6.46] 2.62[1.06; 6.46]NCT04429711 (Biber), 202010%100NAnot evaluable0.55.01.0relative treatment effectwww.metaEvidence.org2024-03-29 15:45 +01:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 87 - treatments: 684,886 - roots T: 290